<DOC>
	<DOCNO>NCT01594970</DOCNO>
	<brief_summary>This study evaluate safety efficacy bimatoprost 0.01 % subject elevate intraocular pressure ( IOP ) due primary open-angle glaucoma ( POAG ) ocular hypertension ( OH ) .</brief_summary>
	<brief_title>A Safety Efficacy Study Bimatoprost 0.01 % Primary Open-Angle Glaucoma ( POAG ) Ocular Hypertension ( OH )</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Glaucoma</mesh_term>
	<mesh_term>Ocular Hypertension</mesh_term>
	<mesh_term>Glaucoma , Open-Angle</mesh_term>
	<mesh_term>Bimatoprost</mesh_term>
	<criteria>Elevated IOP due either primary openangle glaucoma ocular hypertension</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2014</verification_date>
</DOC>